Clinical Trials Directory

Trials / Unknown

UnknownNCT05661630

THE EFFECT OF SEX EDUCATION AND COUNSELING GIVEN TO WOMEN WITH STOMIA WITH THE EX-PLISSIT MODEL ON SEXUAL LIFE

THE EFFECT OF SEX EDUCATION AND COUNSELING GIVEN TO WOMEN WITH STOMIA WITH EX-PLISSIT MODEL ON SEXUAL QUALITY OF LIFE AND SEXUAL LIFE SATISFACTION

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
32 (estimated)
Sponsor
NESLİHAN YILMAZ SEZER · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study, it was aimed to determine the effect of sexual education and counseling given to women with stoma with the Ex-PLISSIT model on their sexual life quality and sexual life satisfaction. H1: Female patients with permanent stoma who were given sexual education and counseling with the EX-PLISSIT model had a higher quality of life score measured by the Sexual Quality of Life scale. H2: Female patients with permanent stoma who were given sexual education and counseling with the EX-PLISSIT model had higher mean scores of sexual life satisfaction.

Conditions

Interventions

TypeNameDescription
OTHEREDUCATION AND COUNSELING WITH EX-PLISSIT MODELIn addition to the routine procedure, the women in the experimental group of the research will be given sexual education and counseling with the EX-PLISSIT model. The steps to be followed in accordance with this model are as follows; Session 1 Permission Limited Information The Specific Suggestions The IT-Intensive Therapy Session 2 At the beginning of the interview, the data forms will be reapplied, and then the homework given in the first session will be discussed. The information that the patient needs in line with his questions will be given within the steps of the Ex-PLISSIT model, within the steps of allowing, limited information, special recommendations and, if necessary, intensive therapy. Session 3 At the beginning of the interview, the data forms will be applied for the last time and the patient's questions, if any, will be answered and the session will be ended.

Timeline

Start date
2023-01-02
Primary completion
2023-12-29
Completion
2023-12-29
First posted
2022-12-22
Last updated
2022-12-22

Source: ClinicalTrials.gov record NCT05661630. Inclusion in this directory is not an endorsement.